lomerizine has been researched along with glutamic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, H; Shimazawa, M; Sukamoto, T; Yokota, K | 1 |
| Akaike, A; Hara, H; Honda, Y; Kashii, S; Shimazawa, M; Toriu, N; Yasuyoshi, H; Zhang, S | 1 |
2 other study(ies) available for lomerizine and glutamic acid
| Article | Year |
|---|---|
Effect of KB-2796, a new diphenylpiperazine Ca2+ antagonist, on glutamate-induced neurotoxicity in rat hippocampal primary cell cultures.
Topics: Animals; Calcium Channel Agonists; Calcium Channel Blockers; Cell Survival; Cells, Cultured; Chelating Agents; Female; Glutamates; Glutamic Acid; Hippocampus; N-Methylaspartate; Nervous System Diseases; Piperazines; Pregnancy; Rats; Rats, Wistar | 1993 |
Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina.
Topics: Animals; Calcium Channel Blockers; Cells, Cultured; Dizocilpine Maleate; Dose-Response Relationship, Drug; Flunarizine; Glutamic Acid; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Piperazines; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2000 |